AAX Biotech to showcase at BIO-Europe 2024 in Stockholm Sweden

AAX Biotech is excited to participate and showcase at BIO-Europe 2024 in Stockholm from 4th-6th November!

Meet our CEO Maria Lisa Knudsen to explore how we can leverage our unique technologies Seqitope™ and Opti-mAb™ to accelerate drug development and enable the development of next-generation antibody therapeutics that are more efficient and have higher developability.

We are proud to join the Swedish Pavilion 🇸🇪, a hub for Sweden’s top life sciences startups. Stop by for round-table discussions and presentations, and connect with us here to discuss how we can push forward drug development.